Page 34 - Andreaf Wainer News Today

Parsons Capital Management Inc. RI raised its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.5% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 81,908 shares of the healthcare product maker’s stock after purchasing an additional 375 shares […]

Abbott Laboratories (NYSE:ABT – Get Free Report) announced its earnings results on Wednesday. The healthcare product maker reported $1.19 earnings per share for the quarter, hitting the consensus estimate of $1.19, MarketWatch Earnings reports. The company had revenue of $10.24 billion during the quarter, compared to analyst estimates of $10.19 billion. Abbott Laboratories had a […]

NBC Securities Inc. acquired a new position in Abbott Laboratories (NYSE:ABT – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 34,856 shares of the healthcare product maker’s stock, valued at approximately $3,375,000. Other large investors also recently […]

NBC Securities Inc. acquired a new stake in Abbott Laboratories (NYSE:ABT – Free Report) in the third quarter, HoldingsChannel reports. The firm acquired 34,856 shares of the healthcare product maker’s stock, valued at approximately $3,375,000. Other institutional investors have also modified their holdings of the company. Fairfield Bush & CO. acquired a new position in […]

Breakwater Capital Group lifted its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 11.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,691 shares of the healthcare product maker’s stock after acquiring an additional 285 shares during the period. […]

MONECO Advisors LLC reduced its position in Abbott Laboratories (NYSE:ABT – Free Report) by 4.8% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,445 shares of the healthcare product maker’s stock after selling 174 shares during the quarter. MONECO Advisors LLC’s holdings in Abbott […]

Breakwater Capital Group increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 11.8% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,691 shares of the healthcare product maker’s stock after purchasing an additional 285 shares during the quarter. Breakwater Capital […]

Kavar Capital Partners Group LLC raised its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 49,704 shares of the healthcare product maker’s stock after acquiring an additional 546 shares during the quarter. Kavar […]

Kavar Capital Partners Group LLC increased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.1% in the third quarter, HoldingsChannel.com reports. The fund owned 49,704 shares of the healthcare product maker’s stock after buying an additional 546 shares during the period. Kavar Capital Partners Group LLC’s holdings in Abbott Laboratories were worth $4,814,000 […]

Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target increased by investment analysts at Citigroup from $123.00 to $126.00 in a report released on Thursday, Benzinga reports. The firm presently has a “buy” rating on the healthcare product maker’s stock. Citigroup’s target price points to a potential upside of 13.44% from the stock’s […]